4914
Takasago International Corporation
2026/02/24
The Company sold 444,038 shares of Hisamitsu Pharmaceutical Co., Inc. held, at 6,082 yen per share, totaling 2,700 million yen, and will record special gains of 2,543 million yen in the fiscal year ending March 2026.
